Smolders, E., de Kanter, C., van 't Veer, N., D'avolio, A., Di Perri, G., Burger, D., & van Wijngaarden, P. (2016). Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine. International Journal of Antimicrobial Agents, 48(3), 347. https://doi.org/10.1016/j.ijantimicag.2016.07.002
Chicago Style (17th ed.) CitationSmolders, E.J, C.T.M.M de Kanter, N. van 't Veer, A. D'avolio, G. Di Perri, D.M Burger, and P. van Wijngaarden. "Effective Treatment of Hepatitis C Virus Infection with Sofosbuvir and Daclatasvir 90 mg in a Patient with Severe Epilepsy on Oxcarbazepine." International Journal of Antimicrobial Agents 48, no. 3 (2016): 347. https://doi.org/10.1016/j.ijantimicag.2016.07.002.
MLA (9th ed.) CitationSmolders, E.J, et al. "Effective Treatment of Hepatitis C Virus Infection with Sofosbuvir and Daclatasvir 90 mg in a Patient with Severe Epilepsy on Oxcarbazepine." International Journal of Antimicrobial Agents, vol. 48, no. 3, 2016, p. 347, https://doi.org/10.1016/j.ijantimicag.2016.07.002.